Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-045695

Chief Legal Officer acquired 80,560 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mazzariello Gina Chief Legal Officer 2024-04-16 Grant or award +80,560 161,932 D
Derivatives
Mazzariello Gina Chief Legal Officer 2024-04-16 Grant or award · Stock Option (right to buy) +110,000 110,000 D
Loading xslF345X05/ownership.xml…